Cholesterol and the risk of grade-specific prostate cancer incidence: evidence from two large prospective cohort studies with up to 37 years' follow up
about
Obesity and cancer: mechanistic insights from transdisciplinary studiesMetabolic profiling of cholesterol and sex steroid hormones to monitor urological diseasesFatostatin displays high antitumor activity in prostate cancer by blocking SREBP-regulated metabolic pathways and androgen receptor signaling.Shared common variants in prostate cancer and blood lipids.Role of serum cholesterol and statin use in the risk of prostate cancer detection and tumor aggressiveness.Serum lipid profile and risk of prostate cancer recurrence: Results from the SEARCH databaseMetabolic serum biomarkers for the prediction of cancer: a follow-up of the studies conducted in the Swedish AMORIS studyStatin use and risk of prostate cancer: Results from the Southern Community Cohort Study.Association of serum lipid levels and prostate cancer severity among Hispanic Puerto Rican menCholesterol and prostate cancer risk: a long-term prospective cohort study.Association between Adult Height and Risk of Colorectal, Lung, and Prostate Cancer: Results from Meta-analyses of Prospective Studies and Mendelian Randomization Analyses.Serum lipid profiles: novel biomarkers predicting advanced prostate cancer in patients receiving radical prostatectomy.Racial Differences in the Association Between Preoperative Serum Cholesterol and Prostate Cancer Recurrence: Results from the SEARCH Database.New players for advanced prostate cancer and the rationalisation of insulin-sensitising medicationBlood lipids and prostate cancer: a Mendelian randomization analysis.LXR, prostate cancer and cholesterol: the Good, the Bad and the Ugly.The Role of Cholesterol in Cancer.Low-density lipoprotein receptors play an important role in the inhibition of prostate cancer cell proliferation by statinsIs PSA related to serum cholesterol and does the relationship differ between black and white men?Should visceral fat, strictly linked to hepatic steatosis, be depleted to improve survival?Influence of serum cholesterol level and statin treatment on prostate cancer aggressiveness.Cholesterol and prostate cancer.low neurotrophin receptor CD271 regulates phenotype switching in melanoma.Statin Use and Risk of Skin Cancer.The Effect of Educational Program Based on PRECEDE Model in Promoting Prostate Cancer Screening in a Sample of Iranian Men.Glucose, lipids and gamma-glutamyl transferase measured before prostate cancer diagnosis and secondly diagnosed primary tumours: a prospective study in the Swedish AMORIS cohort.Ratiometric Raman imaging reveals the new anti-cancer potential of lipid targeting drugs
P2860
Q26786829-3EC295C0-CC9B-4DB3-877B-5ABD91F5B1F2Q28079470-698F076C-496B-408C-8EE1-F441276BAE78Q33856101-E0D96D98-3C06-4A00-B7B1-7B45C47D4FAFQ34001263-2060FAE6-16E4-4825-97CF-4F9C1BD9089FQ34158413-56BC64BA-EF7A-4895-A13A-2BB2FB94EC33Q34458822-EFB19D6E-0C53-4E8F-9B4D-B90AB7CF99C7Q35935362-2D56E15C-1C2E-46F4-B716-E3FE21336A15Q35952232-639A8B63-79B3-4CBE-BF10-DAC301B195C2Q36071094-5D70A601-574B-4B0A-8CB5-311077B4D37CQ36106400-0525D1B1-269A-4439-AB33-BBA7C3EA59C0Q36123803-ADF00DFD-E5F8-40DF-8EFF-50AD37F65276Q36293122-E02930A0-4FE7-449C-8BD7-1F4B727B8B7BQ36655971-06CD1E86-BBD9-4EA6-A364-5D4728A8BAB7Q36734036-0AEA3C9E-B920-4844-A430-A3EFC63DB2BFQ37045556-68658BBE-2399-467E-B0E0-843FE20A3AB5Q38077536-64B4ECC6-A4CB-42FA-B079-C0FB729B9BF2Q38838555-72CAB238-8006-4E31-AF7D-7A5A74798D0AQ38846866-537D000F-0C5A-40F3-BD55-2871706B5AFCQ38968138-B59C70D4-20E6-4041-A4BF-0BD142F23102Q40707324-176149E9-D2B6-4177-B11B-CE930DD274EDQ41470928-5DC3FDA2-AF39-48D6-B15B-4F13495221D5Q42079833-8A28B447-CC57-43A1-B374-A7E326D05B11Q47103221-6003C8B3-1D0B-4247-821C-455D44B82614Q47363564-D0F12BFC-2ACE-4093-BC0C-EE1E0667BD37Q47693786-5D119060-6452-4421-BD88-57A9E18979F2Q49796174-70C18871-9CB1-4AEE-B248-9E17547459F6Q57138111-089DCC11-F5E3-4E82-AB7A-438473677125
P2860
Cholesterol and the risk of grade-specific prostate cancer incidence: evidence from two large prospective cohort studies with up to 37 years' follow up
description
2012 nî lūn-bûn
@nan
2012 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
Cholesterol and the risk of gr ...... with up to 37 years' follow up
@ast
Cholesterol and the risk of gr ...... with up to 37 years' follow up
@en
Cholesterol and the risk of gr ...... with up to 37 years' follow up
@nl
type
label
Cholesterol and the risk of gr ...... with up to 37 years' follow up
@ast
Cholesterol and the risk of gr ...... with up to 37 years' follow up
@en
Cholesterol and the risk of gr ...... with up to 37 years' follow up
@nl
prefLabel
Cholesterol and the risk of gr ...... with up to 37 years' follow up
@ast
Cholesterol and the risk of gr ...... with up to 37 years' follow up
@en
Cholesterol and the risk of gr ...... with up to 37 years' follow up
@nl
P2093
P2860
P356
P1433
P1476
Cholesterol and the risk of gr ...... with up to 37 years' follow up
@en
P2093
Carole Hart
Hing Leung
Kashif Shafique
Khaver Qureshi
P2860
P2888
P356
10.1186/1471-2407-12-25
P407
P577
2012-01-19T00:00:00Z
P5875
P6179
1009288050